Trial: 202011019

Targeting pancreatic cancer with sodium glucose transporter 2 (SGLT2) inhibition

Phase

I

Principal Investigator

Lim, Kian-Huat

Disease Site

Metastatic Disease; Pancreas

Learn more about this study at: clinicaltrials.gov